ALGENEX
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector system for vaccine manufacturing, diagnostic reagents, crystallography, HTS and therapeutic molecules.
ALGENEX
Social Links:
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
2005-01-01
Status:
Active
Contact:
+34 914 524 941
Email Addresses:
[email protected]
Total Funding:
4 M EUR
Technology used in webpage:
Gravatar Profiles Ahosting DINA Hosting
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Protean
Protean is a production of artificial and native recombinant proteins.
VacciZone
Vaccizone is an antigen delivery and vaccine technology development company.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-10-10 | Insud Pharma | Insud Pharma acquired by Algenex | N/A |
Investors List
Cleon Capital
Cleon Capital investment in Venture Round - Algenex
Vita Advisory
Vita Advisory investment in Venture Round - Algenex
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-03-14 | Cocoon Bioscience | Algenex investment in Venture Round - Cocoon Bioscience | 15 M EUR |
More informations about "Algenex"
Company. A team of scientists & biotech experts
In 2022, Algenex was acquired by the founders of the Insud Pharma Group, becoming part of a group of pharmaceutical companies with a presence in more than 50 different countries and marketing products from both the chemical and …See details»
ALGENEX S.L - LinkedIn
ALGENEX S.L | 7,186 followers on LinkedIn. Transforming protein production | We are experts in developing novel sub-unit vaccines Our initial focus is on animal health. We aim to capitalize …See details»
Algenex 2025 Company Profile: Valuation, Investors, Acquisition
Algenex General Information Description. Developer of novel subunit vaccines and a range of bio components designed to manufacture recombinant proteins. The company's technology uses …See details»
News. Latest company information - Algenex
Algenex inaugura su nueva planta de fabricación de vacunas en Tres Cantos con capacidad de producción de hasta 100 millones de dosis vacunales. View more; Sep 13. CrisBio Company. Algenex raises €7.4 million in financing round. …See details»
Human and animal healthcare applications - Algenex
Algenex has more than 20 years’ experience in the veterinary sector and is focused on developing and producing veterinary vaccines using its TopBac® and CrisBio® technology platforms. We have successfully produced more than …See details»
Algenex - Crunchbase Investor Profile & Investments
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector …See details»
Algenex | AseBio - Asociación Empresas Biotecnología
Algenex is a private, venture-backed biotechnology company developing disruptive baculovirus-based technologies for the production of recombinant biologics. Algenex has successfully …See details»
Algenex Company Profile - Office Locations, Competitors ... - Craft
Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells. It …See details»
Algenex - Overview, News & Similar companies | ZoomInfo.com
Mar 24, 2023 Algenex contact info: Phone number: (612) 624-1269 Website: www.algenex.com What does Algenex do? Algenex is a biotechnology company backed by Cleon Capital and …See details»
ALGENEX (Alternative Gene Expression S.L.) - VentureRadar
ALGENEX aims to become the preferred partner for companies whose business requires efficient, robust and scalable protein expression systems. By using Algenex’ technologies, potential …See details»
Algenex - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 Algenex is a series B company based in Madrid (Spain), founded in 2005 by Jose Angel Martinez Escribano. It operates as a Developer of recombinant biologics for animal and …See details»
Algenex - Products, Competitors, Financials, Employees, …
Algenex focuses on protein production within the healthcare sector. Use the CB Insights Platform to explore Algenex's full profile. Algenex - Products, Competitors, Financials, Employees, …See details»
Algenix, Inc. Questions - RocketReach
Algenex is a biotechnology company backed by Cleon Capital and Columbus Venture Partners developing disruptive baculovirus-based technologies for the production of recombinant …See details»
Algenex - Profiles & Contacts - Crunchbase
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
Algenex - News & Analysis - Crunchbase
Nov 18, 2021 Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics . Thursday, September 30, 2021 . Yahoo News Sep 30, 2021 . …See details»
Algenex is Using Moths as Bioreactors for Manufacturing Vaccines
Jan 24, 2020 Algenex now has two proprietary products: TopBac and CrisBio. TopBac is a section of engineered genetic sequence known as a ‘cassette’ that can be inserted into the …See details»
algenex.com
Algenex.comSee details»
Growth factors for synthetic food industry - Algenex
Algenex supplies the essential growth media that makes up >90% of the total cost of cultivated meat. How cultivated meat is made. Real advantages. Our product catalogue today include a …See details»
Algenex - Cleon Capital
Algenex is a Spanish biotech company headquartered in Tres Cantos (Madrid), founded in 2011. The company developed a disrupting technology for the biologics market and its mission is to …See details»
Algenex receives a $3.12 million grant through CEPI to support its ...
CEPI announced in January 2024 that an award of up to $3.12 million will support researchers at Algenex in development of a chrysalis-based baculovirus vaccine platform technology: …See details»